NCT05638295: Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
- State
- Under way
- Phase
- Phase 2
- People
- 105 planned
- Started
- 1 Aug 2024
- Primary completion
- 31 Dec 2028
- Arms
- Cohort I Arm A (sotorasib, panitumumab), Cohort II (sotorasib, panitumumab)
- Results
- None posted
- 6 Dec 2022: Trial registered
- 1 Aug 2024: Trial started